Drug class:Factor Xa inhibitors Medically reviewed byKaci Durbin, MD. Last updated on Jul 25, 2024. Uses Warnings Before taking Dosage Side effects Interactions FAQ What is Xarelto? Xarelto belongs to a class of
DRUG INTERACTIONS Combined P-gp and strong CYP3A inhibitors increase exposure to rivaroxaban and may increase risk of bleeding. Combined P-gp and strong CYP3A inducers decrease exposure to rivaroxaban and may increase risk of thromboembolic events. XARELTO® should not be used in patients with CrCl...
Drug class: factor Xa inhibitors Breastfeeding Patient resources Xarelto drug information Xarelto Starter Pack Professional resources Xarelto prescribing information Rivaroxaban (AHFS Monograph) Related treatment guides Atrial Fibrillation Coronary Artery Disease Cardiovascular Risk Reduction Congenital Heart DiseaseGl...
classified as a low-clearance drug. After intravenous administration of a 1 mg dose the elimination half-life is about 4.5 hours. After oral administration of a 10 mg dose the elimination becomes absorption rate limited with mean terminal half-lives of 7 to 11 hours. Special populations ...
Concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants,seeDrug Interactions A history of traumatic or repeated epidural or spinal punctures A history of spinal deformity or spinal surgery ...
Xarelto Injury Lawyers Principal Law Group attorneys are leaders in the field of dangerous drug litigation and will provide you with the experience, knowledge, and understanding that comes with decades of civil litigation practice and billions of dollars in settlements for our clients. ...
Xarelto Lawsuits Head North.Bayer Inc, is facing aXarelto class action lawsuitfiled in Canada—in Calgary to be precise—alleging its blood thinner is linked to dozens of deaths. The lead plaintiff in this class action alleges that the anticoagulant drug caused her to suffer from an uncontrollab...
Xarelto is described as a “next generation” blood thinner. The drug can help reduce the risk of developing blood clots. Blood clots can travel through the bloodstream to the brain and cause strokes. The FDA approved Xarelto in November 2011 to reduce the risk of stroke and systemic embolism...
Xarelto is a member of a class of drugs known as “direct thrombin inhibitors.” The drug was jointly developed by Bayer and Johnson & Johnson’s Janssen Pharmaceuticals subsidiary, and has grown into a blockbuster medication. Since it was introduced in 2011, millions of Americans have been pre...
When considering a Xarelto lawyer, you should consider a law firm that has the ability to represent clients in all 50 states, and one that has the resources to take on a large corporation like Bayer – TruLaw is not afraid to take on the largest drug and medical device companies in the...